BioAgilytix doubled its customer base from 2013 to 2014 and already doubled again by August of this year. The company has 60 percent organic year-over-year growth and Datin expects to acquire a company in Europe by the end of the year. Last year, it worked with 12 of the 25 largest pharmaceutical and biotechnology companies, a figure that has increased to 19 this year.
Click for full article
Learn how BioAgilytix provides the
See how our PK expertise complements our immunogenicity services by evaluating
Learn why we’re a trusted partner to
What are your specific assay needs? Let’s schedule a conversation to review your
questions and requirements with one of our scientists.
Learn how BioAgilytix provides the
See how our PK expertise complements our immunogenicity services by evaluating
Learn why we’re a trusted partner to
What are your specific assay needs? Let’s schedule a conversation to review your
questions and requirements with one of our scientists.
Platforms
Services